CUBE vs GILD · P/E 25, rev $1.07B vs P/E 18, rev $29.44B
CubeSmart (CUBE) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the CUBE and GILD stock pages for the full models.
Not investment advice.